North America Recombinant Proteins Market Size & Outlook
North America recombinant proteins market, 2018-2030 (US$M)
Related Markets
North America recombinant proteins market highlights
- The North America recombinant proteins market generated a revenue of USD 1,248.9 million in 2024.
- The market is expected to grow at a CAGR of 10.8% from 2025 to 2030.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2024.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 1,248.9 million |
| Market revenue in 2030 | USD 2,305.9 million |
| Growth rate | 10.8% (CAGR from 2024 to 2030) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
| Key market players worldwide | Abcam PLC, Sino Biological, Bio-Techne Corp, Genscript Biotech Corp Class H, Bio-Rad Laboratories Inc, Merck KGaA, Thermo Fisher Scientific Inc, Proteintech Group, Enzo Biochem Inc, Abnova, RayBiotech, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, North America region accounted for 41.4% of the global recombinant proteins market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,455.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Proteins Market Scope
Recombinant Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America recombinant proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to recombinant proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 23.47% in 2024. Horizon Databook has segmented the North America recombinant proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Recombinant Proteins Product Outlook (Revenue, USD Million, 2018-2030)
- Cytokines & Growth Factors
- Interferons (IFNs)
- Interleukins (ILs)
- Others
- Antibodies
- Immune checkpoint proteins
- Virus Antigens
- Enzymes
- Kinases
- Metabolic enzymes
- Others
- Recombinant Regulatory Protein
- Hormones
- Others
- Cytokines & Growth Factors
- North America Recombinant Proteins Application Outlook (Revenue, USD Million, 2018-2030)
- Drug Discovery & Development
- Research
- Others
- Therapeutics
- Biologics
- Vaccines
- Cell & Gene Therapies
- Others
- North America Recombinant Proteins Host Cells Outlook (Revenue, USD Million, 2018-2030)
- Mammalian Systems
- Insect Cells
- Yeast & Fungi
- Bacterial Cells
- Others
- North America Recombinant Proteins End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Diagnostic Laboratories
- Others
Reasons to subscribe to North America recombinant proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America recombinant proteins market databook
-
Our clientele includes a mix of recombinant proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America recombinant proteins market , including forecasts for subscribers. This continent databook contains high-level insights into North America recombinant proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America recombinant proteins market size, by country, 2018-2030 (US$M)
North America Recombinant Proteins Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
